Drug Shortage Report for SANDOZ IRBESARTAN

Last updated on 2020-10-27 History
Report ID 80205
Drug Identification Number 02328488
Brand name SANDOZ IRBESARTAN
Common or Proper name IRBESARTAN
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) IRBESARTAN
Strength(s) 150MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100
ATC code C09CA
ATC description ANGIOTENSIN II ANTAGONISTS, PLAIN
Reason for shortage Requirements related to complying with good manufacturing practices.
Anticipated start date
Actual start date 2018-11-05
Estimated end date 2020-10-23
Actual end date 2020-10-23
Shortage status Resolved
Updated date 2020-10-27
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v46 2020-10-27 French Compare
v45 2020-10-27 English Compare
v44 2020-10-13 French Compare
v42 2020-10-13 English Compare
v43 2020-10-13 English Compare
v41 2020-10-05 French Compare
v40 2020-10-05 English Compare
v39 2020-09-28 French Compare
v38 2020-09-28 English Compare
v37 2020-09-21 French Compare
v36 2020-09-21 English Compare
v34 2020-08-26 French Compare
v35 2020-08-26 French Compare
v33 2020-08-26 English Compare
v32 2020-06-29 French Compare
v31 2020-06-29 English Compare
v30 2020-06-08 French Compare
v29 2020-06-08 English Compare
v28 2020-05-11 French Compare
v27 2020-05-11 English Compare

Showing 1 to 20 of 46